The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
Shuai Xia(Shanghai Medical College of Fudan University), Shibo Jiang(Shanghai Medical College of Fudan University), Zezhong Liu(Ministry of Education), Qiaoshuai Lan(Chinese University of Hong Kong), Yun Zhu(Chinese Academy of Sciences), Lu Lu(Shanghai Medical College of Fudan University), Qian Wang(Shanghai Medical College of Fudan University), Shan Su(New York Blood Center), Xinling Wang(Fudan University), Wei Xu(Beijing Geriatric Hospital)
Cited by 363
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron
|RePEc: Research Papers in Economics|0|647
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
|Nature Communications|2014|400